GTSF1L
gene geneOn this page
Also known as dJ1028D15.4
Summary
GTSF1L (gametocyte specific factor 1 like, HGNC:16198) is a protein-coding gene on chromosome 20q13.12, encoding Gametocyte-specific factor 1-like (Q9H1H1).
Predicted to enable zinc ion binding activity.
Source: NCBI Gene 149699 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_176791
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16198 |
| Approved symbol | GTSF1L |
| Name | gametocyte specific factor 1 like |
| Location | 20q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ1028D15.4 |
| Ensembl gene | ENSG00000124196 |
| Ensembl biotype | protein_coding |
| Entrez | 149699 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000373003, ENST00000373005
RefSeq mRNA: 2 — MANE Select: NM_176791
NM_001008901, NM_176791
CCDS: CCDS13323, CCDS33471
Canonical transcript exons
ENST00000373003 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001459278 | 43726164 | 43727002 |
Expression profiles
Bgee: expression breadth ubiquitous, 114 present calls, max score 98.34.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4972 / max 440.2589, expressed in 10 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187304 | 0.3638 | 9 |
| 187305 | 0.1148 | 3 |
| 209117 | 0.0187 | 4 |
Top tissues by expression
192 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.34 | gold quality |
| left testis | UBERON:0004533 | 97.69 | gold quality |
| right testis | UBERON:0004534 | 97.69 | gold quality |
| adult organism | UBERON:0007023 | 95.98 | gold quality |
| testis | UBERON:0000473 | 95.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.63 | gold quality |
| kidney epithelium | UBERON:0004819 | 88.73 | gold quality |
| vena cava | UBERON:0004087 | 83.38 | silver quality |
| superficial temporal artery | UBERON:0001614 | 82.07 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 80.72 | gold quality |
| upper arm skin | UBERON:0004263 | 80.68 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 80.40 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 80.28 | silver quality |
| cerebellar vermis | UBERON:0004720 | 79.10 | silver quality |
| lower lobe of lung | UBERON:0008949 | 78.70 | silver quality |
| gingival epithelium | UBERON:0001949 | 77.15 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 76.22 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 75.86 | silver quality |
| epithelium of mammary gland | UBERON:0003244 | 74.78 | gold quality |
| biceps brachii | UBERON:0001507 | 74.66 | silver quality |
| mammary duct | UBERON:0001765 | 74.65 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 73.93 | silver quality |
| gingiva | UBERON:0001828 | 73.36 | silver quality |
| oocyte | CL:0000023 | 73.29 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 72.93 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 72.87 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 72.31 | silver quality |
| cardia of stomach | UBERON:0001162 | 72.18 | silver quality |
| trachea | UBERON:0003126 | 71.53 | gold quality |
| superior surface of tongue | UBERON:0007371 | 71.30 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 2074.49 |
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gtsf1 | ENSDARG00000000887 |
| danio_rerio | ENSDARG00000099586 | |
| mus_musculus | Gtsf1l | ENSMUSG00000070708 |
| rattus_norvegicus | Gtsf1l | ENSRNOG00000069924 |
| drosophila_melanogaster | arx | FBGN0036826 |
Paralogs (2): SNRNP48 (ENSG00000168566), GTSF1 (ENSG00000170627)
Protein
Protein identifiers
Gametocyte-specific factor 1-like — Q9H1H1 (reviewed: Q9H1H1)
Alternative names: Protein FAM112A
All UniProt accessions (1): Q9H1H1
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the UPF0224 (FAM112) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H1H1-1 | 1 | yes |
| Q9H1H1-2 | 2 |
RefSeq proteins (2): NP_001008901, NP_789761* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR022776 | TRM13/UPF0224_CHHC_Znf_dom | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051591 | UPF0224_FAM112_RNA_Proc | Family |
Pfam: PF05253
UniProt features (15 total): binding site 8, zinc finger region 2, chain 1, splice variant 1, sequence variant 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H1H1-F1 | 75.73 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 49; 59; 63; 9; 15; 25; 29; 43
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
FOSTER_KDM1A_TARGETS_UP, GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING, TFEB_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP, GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP, GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN, OUILLETTE_CLL_13Q14_DELETION_DN, GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN, GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP, GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP, SYATTGTG_UNKNOWN, NOTCH3_TARGET_GENES, GSE17721_4_VS_24H_CPG_BMDC_UP, GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP, GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN
GO Biological Process (0):
GO Molecular Function (4): zinc ion binding (GO:0008270), protein-containing complex binding (GO:0044877), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| transition metal ion binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
414 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GTSF1L | TMEM225 | Q6GV28 | 641 |
| GTSF1L | TMEM270 | Q6UE05 | 572 |
| GTSF1L | GARIN1B | Q96KD3 | 505 |
| GTSF1L | C5orf58 | C9J3I9 | 503 |
| GTSF1L | FAM151B | Q6UXP7 | 490 |
| GTSF1L | HEATR9 | A2RTY3 | 476 |
| GTSF1L | FSCN3 | Q9NQT6 | 472 |
| GTSF1L | SPATS1 | Q496A3 | 471 |
| GTSF1L | TDRD1 | Q9BXT4 | 458 |
| GTSF1L | SPATA3 | Q8NHX4 | 448 |
| GTSF1L | RSPRY1 | Q96DX4 | 437 |
| GTSF1L | SPACA4 | Q8TDM5 | 431 |
| GTSF1L | SNRNP48 | Q6IEG0 | 407 |
| GTSF1L | FAM25A | B3EWG3 | 400 |
| GTSF1L | ARMC1 | Q9NVT9 | 398 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GSC2 | GTSF1L | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTSF1L | HELLS | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTSF1L | VPS26B | psi-mi:“MI:0914”(association) | 0.350 |
| GTSF1L | GSC2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HELLS | GTSF1L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): GTSF1L (Two-hybrid), GTSF1L (Two-hybrid), VPS26B (Affinity Capture-MS), THUMPD3 (Affinity Capture-MS), WDR54 (Affinity Capture-MS), PRUNE (Affinity Capture-MS)
ESM2 similar proteins: A0JMR6, A4IIA7, A5WW08, O60934, P14629, P55265, P79457, Q13434, Q149N8, Q2YDS5, Q3B7T1, Q3KQ71, Q3SZU0, Q3T026, Q3UDK1, Q4R8M9, Q4VBT5, Q561R3, Q5FWP4, Q5R4U2, Q5RCV3, Q5RGA4, Q5RL73, Q5VVJ2, Q66J91, Q69Z66, Q6A098, Q6IEG0, Q6P256, Q6PFK1, Q7TN31, Q7ZZ00, Q8JFF3, Q8K2X2, Q8N302, Q8S4P6, Q8WW33, Q93073, Q96T68, Q99MM4
Diamond homologs: Q3T026, Q9CWD0, Q9H1H1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
223 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:43726456:A:AC | donor_gain | 0.9500 |
| 20:43726457:C:CC | donor_gain | 0.9500 |
| 20:43726460:T:A | donor_gain | 0.7800 |
| 20:43726358:G:A | donor_gain | 0.7400 |
| 20:43726457:CTTT:C | donor_gain | 0.7300 |
| 20:43726721:A:AC | donor_gain | 0.7300 |
| 20:43726722:C:CC | donor_gain | 0.7300 |
| 20:43726486:T:TA | donor_gain | 0.7200 |
| 20:43726518:ATGTT:A | donor_gain | 0.7000 |
| 20:43726323:C:CC | acceptor_gain | 0.6900 |
| 20:43726522:T:TA | donor_gain | 0.6900 |
| 20:43726382:T:A | donor_gain | 0.6300 |
| 20:43726319:CAAC:C | acceptor_gain | 0.6100 |
| 20:43726368:AGCG:A | donor_gain | 0.6100 |
| 20:43726418:G:A | donor_gain | 0.6000 |
| 20:43726717:T:TA | donor_gain | 0.6000 |
| 20:43726984:A:AC | donor_gain | 0.6000 |
| 20:43726985:C:CC | donor_gain | 0.6000 |
| 20:43726321:ACC:A | acceptor_loss | 0.5800 |
| 20:43726322:CCT:C | acceptor_loss | 0.5800 |
| 20:43726326:T:TC | acceptor_gain | 0.5800 |
| 20:43726477:T:TA | donor_gain | 0.5800 |
| 20:43726544:C:CT | donor_gain | 0.5800 |
| 20:43726722:CTG:C | donor_gain | 0.5700 |
| 20:43726355:CATG:C | donor_gain | 0.5600 |
| 20:43726496:T:A | donor_gain | 0.5600 |
| 20:43726510:ACAG:A | donor_gain | 0.5600 |
| 20:43726511:CAGC:C | donor_gain | 0.5600 |
| 20:43726369:G:C | donor_gain | 0.5500 |
| 20:43726443:A:C | donor_gain | 0.5500 |
AlphaMissense
988 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:43726548:G:C | H49Q | 0.982 |
| 20:43726548:G:T | H49Q | 0.982 |
| 20:43726620:G:C | H25Q | 0.980 |
| 20:43726620:G:T | H25Q | 0.980 |
| 20:43726622:G:C | H25D | 0.980 |
| 20:43726652:G:C | H15D | 0.979 |
| 20:43726574:C:G | A41P | 0.976 |
| 20:43726670:A:G | C9R | 0.975 |
| 20:43726650:G:C | H15Q | 0.971 |
| 20:43726650:G:T | H15Q | 0.971 |
| 20:43726561:T:G | Y45S | 0.966 |
| 20:43726609:C:G | C29S | 0.966 |
| 20:43726610:A:T | C29S | 0.966 |
| 20:43726568:A:G | C43R | 0.965 |
| 20:43726622:G:T | H25N | 0.964 |
| 20:43726557:G:C | N46K | 0.960 |
| 20:43726557:G:T | N46K | 0.960 |
| 20:43726632:T:A | R21S | 0.958 |
| 20:43726632:T:G | R21S | 0.958 |
| 20:43726562:A:C | Y45D | 0.957 |
| 20:43726567:C:G | C43S | 0.955 |
| 20:43726568:A:T | C43S | 0.955 |
| 20:43726652:G:T | H15N | 0.954 |
| 20:43726669:C:G | C9S | 0.952 |
| 20:43726670:A:T | C9S | 0.952 |
| 20:43726518:A:C | H59Q | 0.950 |
| 20:43726518:A:T | H59Q | 0.950 |
| 20:43726630:A:G | F22S | 0.950 |
| 20:43726664:A:C | Y11D | 0.949 |
| 20:43726618:A:G | L26P | 0.948 |
dbSNP variants (sampled 300 via entrez): RS1000295175 (20:43727160 TTTTTTG>T,TTTTTTGTTTTTG), RS1000779207 (20:43726879 T>A), RS1001652071 (20:43727378 G>A), RS1002019368 (20:43727585 A>G), RS1005086506 (20:43728190 T>C), RS1005629066 (20:43727763 C>T), RS1007263098 (20:43728618 T>C,G), RS1007800288 (20:43726853 CTG>C), RS1009222553 (20:43727961 A>G), RS1013375212 (20:43726172 G>A), RS1014154957 (20:43727231 G>A,T), RS1014385398 (20:43727359 G>A), RS1016899118 (20:43725927 CAT>C), RS1018310587 (20:43726868 T>C), RS1018902476 (20:43727967 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | increases expression | 1 |
| terbufos | increases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| clothianidin | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.